how does glp-1 agonist suppress appetite Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements The central and peripheral effects

Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 19 Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations Authors Ylmaz N , Bastemir M Received 27 November 2025 Accepted for publication 13 January 2026 Published 30 January 2026 Volume 2026:19 584175 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Halis Akturk Nimet Ylmaz, 1 Mehmet Bastemir 2 1 Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey

This can lead to the following side effects: Lower muscle mass and body composition

GH release is documented beginning within 515 minutes

RT-qPCR was performed on CFX-96 (BioRad, CA)

Explore the potential benefits of our pharmaceutical-grade supplements, which encompass a wide range of wellness needs